Patents Assigned to Compellis Pharmaceuticals
  • Inhibition of olfactory neurosensory function to treat eating disorders and obesity
    Patent number: 7435407
    Abstract: The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: October 14, 2008
    Assignee: Compellis Pharmaceuticals
    Inventors: Christopher P. Adams, James Flynn
  • Inhibition of olfactory neurosensory function to treat eating disorders and obesity
    Publication number: 20070025921
    Abstract: The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.
    Type: Application
    Filed: September 27, 2006
    Publication date: February 1, 2007
    Applicant: Compellis Pharmaceuticals
    Inventors: Christopher Adams, James Flynn
  • Inhibition of olfactory neurosensory function to treat eating disorders and obesity
    Patent number: 7138107
    Abstract: The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.
    Type: Grant
    Filed: February 18, 2003
    Date of Patent: November 21, 2006
    Assignee: Compellis Pharmaceuticals
    Inventors: Christopher P. Adams, James Flynn
  • Inhibition of olfactory neurosensory function to treat eating disorders and obesity
    Publication number: 20040167117
    Abstract: The use of calcium channel blockers administered intra-nasally to inhibit olfactory sensory perception to treat eating disorders, including obesity, is described. Also described is a method of reducing food intake in a subject by administering a pharmaceutical composition comprising an effective amount of a calcium channel blocker to the nasal mucosa, as well as screening methods for drugs to be used in treating obesity or associated disorders.
    Type: Application
    Filed: February 18, 2003
    Publication date: August 26, 2004
    Applicant: COMPELLIS PHARMACEUTICALS
    Inventors: Christopher P. Adams, James Flynn